Issue: January 2016
January 15, 2016
1 min read
Save

Intracameral amphotericin B prevents progression of fungal corneal ulcers

Issue: January 2016
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Intracameral amphotericin B resulted in faster healing of ulcers and fewer complications than conventional treatment in eyes with fungal keratitis, according to a study.

The prospective, nonrandomized study included 104 eyes of 104 patients with fungal corneal ulcers. Forty-nine eyes (group A) responded to conventional topical and systemic antifungal medication and showed signs of healing within 7 days. Fifty-five eyes (group B) did not respond within 7 days and received intracameral amphotericin B in a dose of 5 µg to 10 µg in 1 mL of 5% dextrose.

Final mean logMAR visual acuity was 1.25 in group A and 1.22 in group B. Mean visual acuity improved 0.55 in group A and 1.40 in group B.

In group B, healing with various amounts of opacification occurred in 81.48% of patients, significantly more than in group A (P < .05).

Ulcer healing occurred in 1 week to 3 weeks in 87.7% of patients in group A. Mean time to healing was 13.08 days. Complete epithelialization and healing occurred in 1 week to 2 weeks in 52.7% of patients in group B. Mean time for ulcer healing was 12.37 days.

Hypopyon disappeared in 17.12 days in group A and 13.4 days in group B.

The incidence of complications such as sloughing was significantly lower in group B than in group A (P < .05). – by Matt Hasson

Disclosure: The authors report no relevant financial disclosures.